CD19 and acute lymphoblastic leukemia: Mechanistically, ARRB1-mediated epigenetic regulation of the tumor suppressor PTEN plays a key role in maintaining the self-renewal potential in the cancer stem cell-enriched CD34+CD38-CD19+ population of B-ALL [62].